-
-
-
-
-
-
-
Centessa Pharmaceuticals (CNTA) call put ratio 3.7 calls to 1 put after Eli Lilly (LLY) acquiring
-
-
-
-
-
-
-
CENTESSA presents preclinical data on depression treatment candidate
-
-
-
-
-
-
-
Centessa Pharmaceuticals (CNTA) PT Raised to $43 at Guggenheim
-
-
-
-
-
-
-
Canaccord #1 Key Risk to AxoGen, Inc. (AXGN): 'the FDA running out of carryover funding and needing to halt work'
-
-
-
-
-
-
-
Centessa Pharmaceuticals plc (CNTA) Tops Q1 EPS by 16c
-
-
-
-
-
-
-
Centessa Pharmaceuticals (CNTA) PT Raised to $24 at Leerink Partners
-
-
-
-
-
-
-
Centessa Pharmaceuticals (CNTA) Announces $150M ADS Offering
-
435,351 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

